Pluri (PLUR) Net Margin (2011 - 2025)

Pluri (PLUR) reported Net Margin of 4546444.95% for Q4 2025, up 154729630.0% year-over-year from N/an in Q4 2024, and up 79.8% quarter-over-quarter from 2528587.03% in Q3 2025.

Pluri (PLUR) Net Margin (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 12 years of Net Margin data on file, last reported at 4546444.95% in Q4 2025.

  • Net Margin for Q4 2025 came in at 4546444.95%, up 154729630.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1268097.83% (down 35301588.0% YoY), and the FY2025 annual result was 473988.55%, down 113206759.0% from the prior year.
  • Net Margin rose to 4546444.95% in Q4 2025 per PLUR's latest filing, from 2528587.03% in the prior quarter.
  • Over five years, Net Margin peaked at 4546444.95% in Q4 2025 and troughed at 344550.0% in Q4 2022.
  • A 4-year average of 760085.37% and a median of 4671.43% in 2023 frame the typical range for Net Margin.
  • On a YoY basis, Net Margin climbed as much as 299447722 bps in 2024 and fell as far as 1701865 bps in 2024.
  • A 4-year view of Net Margin shows it stood at 344550.0% in 2022, then surged by 101 bps to 4671.43% in 2023, then soared by 64102 bps to 2999148.65% in 2024, then surged by 52 bps to 4546444.95% in 2025.
  • Business Quant data shows PLUR's Net Margin at 4546444.95% in Q4 2025, 2528587.03% in Q3 2025, and 1722.11% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 4,546,444.95%

Historic Data

Download Data
DateValue
Dec 31, 2025 4,546,444.95%
Sep 30, 2025 2,528,587.03%
Jun 30, 2025 -1,722.11%
Mar 31, 2025 -1,314.29%
Dec 31, 2024 2,999,148.65%
Sep 30, 2024 1,673,230.06%
Jun 30, 2024 -6,512.50%
Mar 31, 2024 -8,101.41%
Dec 31, 2023 4,671.43%
Sep 30, 2023 9,187.04%
Jun 30, 2023 5,951.35%
Mar 31, 2023 8,917.24%
Dec 31, 2022 -344,550.00%
Sep 30, 2022 -8,180.46%
Mar 31, 2022 -4,476.50%
Dec 31, 2019 -27,686.96%
Dec 31, 2018 -16,662.00%
Sep 30, 2018 -224,250.00%
Dec 31, 2017 -16,934.00%
Dec 31, 2015 -153.63%